FDA Approves Rivaroxaban for CV Prevention in CAD, PAD
(MedPage Today) -- Low dose to arrive in the U.S. next week
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | International Medicine & Public Health